Metabolic reprogramming is an emerging topic in cancer research. However, genetic alterations in genes encoding enzymes involved in amino acid metabolism are largely unknown. The aim of this study was to explore whether genes known to be involved in amino acid metabolism are mutated in gastric cancer (GC) and/or colorectal cancer (CRC).
Through a public database search, we found that a number of genes known to be involved in amino acid metabolism, i.e., AGXT, ALDH2, APIP, MTR, DNMT1, ASH1L, ASPA, CAD, DDC, GCDH, DLD, LAP3, MCEE and MUT, harbor mononucleotide repeats that may serve as mutation targets in cancers exhibiting microsatellite instability (MSI). We assessed these genes for the presence of the mutations in 79 GCs and 124 CRCs using single-strand conformation polymorphism (SSCP) and direct sequencing analyses.
Using SSCP in conjunction with DNA sequencing we detected frameshift mutations in AGXT (17 cases), ALDH2 (3 cases), APIP (4 cases), MTR (5 cases), DNMT1 (1 case), ASH1L (1 case), ASPA (2 cases), CAD (2 cases), DDC (1 case), GCDH (3 cases), DLD (1 case), LAP3 (1 case), MCEE (5 cases) and MUT (1 case). These mutations were exclusively detected in MSI-high (MSI-H), and not in MSI-low or MSI-stable (MSI-L/MSS) cases. In addition, we analyzed 16 CRCs for the presence of intra-tumor heterogeneity (ITH) and found that two CRCs harbored regional ITH for GCDH frameshift mutations.
Our data indicate that genes known to be involved in amino acid metabolism recurrently acquire somatic mutations in MSH-H GCs and MSH-H CRCs and that, in addition, mutation ITH does occur in at least some of these tumors. Together, these data suggest that metabolic reprogramming may play a role in the etiology of MSI-H GCs and CRCs. Our data also suggest that ultra-regional mutation analysis is required for a more comprehensive evaluation of the mutation status in these tumors.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)
R.G. Jones, C.B. Thompson, Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 23, 537–548 (2009)
C. Muñoz-Pinedo, N. El Mjiyad, J.E. Ricci, Cancer metabolism: current perspectives and future directions. Cell Death Dis. 3, e248 (2012)
H. Eagle, Nutrition needs of mammalian cells in tissue culture. Science 122, 501–514 (1955)
J.W. Locasale, A.R. Grassian, T. Melman, C.A. Lyssiotis, K.R. Mattaini, A.J. Bass, G. Heffron, C.M. Metallo, T. Muranen, H. Sharfi, A.T. Sasaki, D. Anastasiou, E. Mullarky, N.I. Vokes, M. Sasaki, R. Beroukhim, G. Stephanopoulos, A.H. Ligon, M. Meyerson, A.L. Richardson, L. Chin, G. Wagner, J.M. Asara, J.S. Brugge, L.C. Cantley, M.G. Vander Heiden, Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43, 869–874 (2011)
D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, G.L. Gallia, A. Olivi, R. McLendon, B.A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D.A. Busam, H. Tekleab, L.A. Diaz Jr., J. Hartigan, D.R. Smith, R.L. Strausberg, S.K. Marie, S.M. Shinjo, H. Yan, G.J. Riggins, D.D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, K.W. Kinzler, An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008)
H. Yan, D.W. Parsons, G. Jin, R. McLendon, B.A. Rasheed, W. Yuan, I. Kos, I. Batinic-Haberle, S. Jones, G.J. Riggins, H. Friedman, A. Friedman, D. Reardon, J. Herndon, K.W. Kinzler, V.E. Velculescu, B. Vogelstein, D.D. Bigner, IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009)
F. Wang, J. Travins, B. DeLaBarre, V. Penard-Lacronique, S. Schalm, E. Hansen, K. Straley, A. Kernytsky, W. Liu, C. Gliser, H. Yang, S. Gross, E. Artin, V. Saada, E. Mylonas, C. Quivoron, J. Popovici-Muller, J.O. Saunders, F.G. Salituro, S. Yan, S. Murray, W. Wei, Y. Gao, L. Dang, M. Dorsch, S. Agresta, D.P. Schenkein, S.A. Biller, S.M. Su, S. de Botton, K.E. Yen, Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science 340, 622–626 (2013)
K. Imai, H. Yamamoto, Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29, 673–680 (2008)
N. Rampino, H. Yamamoto, Y. Ionov, Y. Li, H. Sawai, J.C. Reed, M. Perucho, Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967–969 (1997)
A. Marusyk, V. Almendro, K. Polyak, Intra-tumour heterogeneity: a looking glass for cancer? Nat. Rev. Cancer 12, 323–334 (2012)
B. Cellini, R. Montioli, A. Paiardini, A. Lorenzetto, C.B. Voltattorni, Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine:glyoxylate aminotransferase and the F152I mutation. J. Biol. Chem. 27(284), 8349–8358 (2009)
C.C. Chen, R.B. Lu, Y.C. Chen, M.F. Wang, Y.C. Chang, T.K. Li, S.J. Yin, Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am. J. Hum. Genet. 65, 795–807 (1999)
D.H. Cho, Y.M. Hong, H.J. Lee, H.N. Woo, J.O. Pyo, T.W. Mak, Y.K. Jung, Induced inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1-interacting protein. J. Biol. Chem. 279, 39942–39950 (2004)
S. Gulati, P. Baker, Y.N. Li, B. Fowler, W. Kruger, L.C. Brody, R. Banerjee, Defects in human methionine synthase in cblG patients. Hum. Mol. Genet. 5, 1859–1865 (1996)
D.W. Hsu, M.J. Lin, T.L. Lee, S.C. Wen, X. Chen, C.K. Shen, Two major forms of DNA (cytosine-5) methyltransferase in human somatic tissues. Proc. Natl. Acad. Sci. U. S. A. 96, 9751–9756 (1999)
T. Nakamura, J. Blechman, S. Tada, T. Rozovskaia, T. Itoyama, F. Bullrich, A. Mazo, C.M. Croce, B. Geiger, E. Canaani, huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions. Proc. Natl. Acad. Sci. U. S. A. 97, 7284–7289 (2000)
R. Kaul, K. Balamurugan, G.P. Gao, R. Matalon, Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. Genomics 21, 364–370 (1994)
J.P. Simmer, R.E. Kelly, A.G. Jr, B.H. Rinker, J.L. Zimmermann, H. Scully, D.R.E. Kim, Mammalian dihydroorotase: nucleotide sequence, peptide sequences, and evolution of the dihydroorotase domain of the multifunctional protein CAD. Proc. Natl. Acad. Sci. U. S. A. 87(174–178) (1990)
R. Pons, B. Ford, C.A. Chiriboga, P.T. Clayton, V. Hinton, K. Hyland, R. Sharma, D.C. De Vivo, Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis. Neurology 62, 1058–1065 (2004)
A.C. Lenich, S.I. Goodman, The purification and characterization of glutaryl-coenzyme A dehydrogenase from porcine and human liver. J. Biol. Chem. 261, 4090–4096 (1986)
O.N. Elpeleg, A. Shaag, J.Z. Glustein, Y. Anikster, A. Joseph, A. Saada, Lipoamide dehydrogenase deficiency in Ashkenazi Jews: an insertion mutation in the mitochondrial leader sequence. Hum. Mutat. 10, 256–257 (1997)
S. Zhang, X. Yang, H. Shi, M. Li, Q. Xue, H. Ren, L. Yao, X. Chen, J. Zhang, H. Wang, Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma. J. Mol. Histol. 45, 283–292 (2014)
H. Bikker, H.D. Bakker, N.G. Abeling, B.T. Poll-The, W.J. Kleijer, D.S. Rosenblatt, H.R. Waterham, R.J. Wanders, M. Duran, A homozygous nonsense mutation in the methylmalonyl-CoA epimerase gene (MCEE) results in mild methylmalonic aciduria. Hum. Mutat. 27, 640–643 (2006)
R. Jansen, F.D. Ledley, Heterozygous mutations at the mut locus in fibroblasts with mut0 methylmalonic acidemia identified by polymerase-chain-reaction cDNA cloning. Am. J. Hum. Genet. 47, 808–814 (1990)
K. Murphy, S. Zhang, T. Geiger, M.J. Hafez, J. Bacher, K.D. Berg, J.R. Eshleman, Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J. Mol. Diagn. 8, 305–311 (2006)
J.W. Lee, Y.H. Soung, S.Y. Kim, H.W. Lee, W.S. Park, S.W. Nam, S.H. Kim, J.Y. Lee, N.J. Yoo, S.H. Lee, PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24, 1477–1480 (2005)
N.J. Yoo, H.R. Kim, Y.R. Kim, C.H. An, S.H. Lee, Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 60, 943–952 (2012)
E.M. Je, M.R. Kim, K.O. Min, N.J. Yoo, S.H. Lee, Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int. J. Cancer 131, E1044–1047 (2012)
X.M. Ma, J. Blenis, Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307–318 (2009)
D. Mouradov, C. Sloggett, R.N. Jorissen, C.G. Love, S. Li, A.W. Burgess, D. Arango, R.L. Strausberg, D. Buchanan, S. Wormald, L. O’Connor, J.L. Wilding, D. Bicknell, I.P. Tomlinson, W.F. Bodmer, J.M. Mariadason, O.M. Sieber, Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res. 74, 3238–3247 (2014)
F.A. Duijkers, R.X. de Menezes, I.J. Goossens-Beumer, D.J. Stumpel, P. Admiraal, R. Pieters, J.P. Meijerink, M.M. van Noesel, Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines. Cell. Oncol. 36, 351–362 (2013)
A. Geurts van Kessel, The cancer genome: from structure to function. Cell. Oncol. 37, 155–165 (2014)
M.F. Paz, S. Avila, M.F. Fraga, M. Pollan, G. Capella, M.A. Peinado, M. Sanchez-Cespedes, J.G. Herman, M. Esteller, Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res. 62, 4519–4524 (2002)
L.M. Graves, H.I. Guy, P. Kozlowski, M. Huang, E. Lazarowski, R.M. Pope, M.A. Collins, E.N. Dahlstrand, H.S. Earp 3rd, D.R. Evans, Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature 403, 328–332 (2000)
L. Gamelin, O. Capitain, A. Morel, A. Dumont, S. Traore, B. le Anne, S. Gilles, M. Boisdron-Celle, E. Gamelin, Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway. Clin. Cancer Res. 13, 6359–6368 (2007)
G.A. Calin, R. Gaf, M.G. Tibiletti, V. Herlea, G. Becheanu, L. Cavazzini, G. Barbanti-Brodano, I. Nenci, M. Negrini, G. Lanza, Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int. J. Cancer 89, 230–235 (2000)
T.M. Kim, S.H. Jung, I.P. Baek, S.H. Lee, Y.J. Choi, J.Y. Lee, Y.J. Chung, S.H. Lee, Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer. J. Pathol. 233, 425–435 (2014)
O. Krijgsman, D. Israeli, H.F. van Essen, P.P. Eijk, M.L. Berens, C.H. Mellink, A.W. Nieuwint, M.M. Weiss, R.D. Steenbergen, G.A. Meijer, B. Ylstra, Detection limits of DNA copy number alterations in heterogeneous cell populations. Cell. Oncol. 36, 27–36 (2013)
This work was supported by a grant from National Research Foundation of Korea (2012R1A5A2047939).
Conflicts of interest
None to declare.
MRC and SHL wrote the manuscript. MRC performed the experimental work. NJY and SHL performed the pathological examinations. SHL and ACH designed the work.
About this article
Cite this article
Oh, H.R., An, C.H., Yoo, N.J. et al. Somatic mutations of amino acid metabolism-related genes in gastric and colorectal cancers and their regional heterogeneity - a short report. Cell Oncol. 37, 455–461 (2014). https://doi.org/10.1007/s13402-014-0209-1
- Amino acid metabolism
- Frameshift mutations
- Gastrointestinal cancers
- Microsatellite instability